123 related articles for article (PubMed ID: 27042808)
21. Antiretroviral drugs for prevention of mother-to-child transmission: pharmacologic considerations for a public health approach.
Lamorde M; Schapiro JM; Burger D; Back DJ
AIDS; 2014 Nov; 28(17):2551-63. PubMed ID: 25574958
[TBL] [Abstract][Full Text] [Related]
22. Characterization of stress degradation products of benazepril by using sophisticated hyphenated techniques.
Narayanam M; Sahu A; Singh S
J Chromatogr A; 2013 Jan; 1271(1):124-36. PubMed ID: 23237710
[TBL] [Abstract][Full Text] [Related]
23. Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
Marcelin AG; Charpentier C; Wirden M; Landman R; Valantin MA; Simon A; Katlama C; Yeni P; Descamps D; Aubron-Olivier C; Calvez V
J Antimicrob Chemother; 2012 Jun; 67(6):1475-8. PubMed ID: 22371439
[TBL] [Abstract][Full Text] [Related]
24. Identification and structural characterization of hydrolytic degradation products of alvimopan by LC/QTOF/MS/MS and NMR studies.
Baira SM; R S; Talluri MVNK
J Pharm Biomed Anal; 2019 Feb; 165():399-409. PubMed ID: 30590338
[TBL] [Abstract][Full Text] [Related]
25. Insights into the degradation chemistry of tazarotene, a third generation acetylenic retinoid: LC-HRMS (Orbitrap), LC-MS
Singh DK; Sahu A; Balhara A; Giri S; Singh S
J Pharm Biomed Anal; 2020 Jul; 186():113316. PubMed ID: 32413825
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/emtricitabine and abacavir/lamivudine.
Vourvahis M; Davis J; Langdon G; Layton G; Fang J; Choo HW; Hansson AG; Tawadrous M
Antivir Ther; 2013; 18(6):745-54. PubMed ID: 23558061
[TBL] [Abstract][Full Text] [Related]
27. Determination of enantiomeric impurity of tenofovir disoproxil fumarate on a cellulose tris(3,5-dichlorophenyl-carbamate) chiral stationary phase and the characterization of its related substances.
Nguyen BT; Le TA; Mai XL; Nguyen TNV; Phan TD; Kang JS; Kim KH
J Sep Sci; 2021 May; 44(10):2029-2036. PubMed ID: 33682357
[TBL] [Abstract][Full Text] [Related]
28. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.
Yamada E; Takagi R; Sudo K; Kato S
J Pharm Biomed Anal; 2015 Oct; 114():390-7. PubMed ID: 26112927
[TBL] [Abstract][Full Text] [Related]
29. Stability behaviour of antiretroviral drugs and their combinations. 11: Characterization of interaction products of zidovudine and efavirenz, and evaluation of their anti HIV-1 activity, and physiochemical and ADMET properties.
Kurmi M; Sahu A; Balhara A; Singh IP; Kulkarni S; Singh NK; Garg P; Singh S
J Pharm Biomed Anal; 2020 Jan; 178():112911. PubMed ID: 31627078
[TBL] [Abstract][Full Text] [Related]
30. A LC-MS method to quantify tenofovir urinary concentrations in treated patients.
Simiele M; Carcieri C; De Nicolò A; Ariaudo A; Sciandra M; Calcagno A; Bonora S; Di Perri G; D'Avolio A
J Pharm Biomed Anal; 2015 Oct; 114():8-11. PubMed ID: 25997174
[TBL] [Abstract][Full Text] [Related]
31. Solid Forms of Tenofovir Disoproxil Fumarate, Their Mutual Conversion, and Stabilization of Form I in Formulation.
Sládková V; Dammer O; Kratochvíl B
J Pharm Sci; 2016 Oct; 105(10):3136-3142. PubMed ID: 27522525
[TBL] [Abstract][Full Text] [Related]
32. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Walmsley SL; Antela A; Clumeck N; Duiculescu D; Eberhard A; Gutiérrez F; Hocqueloux L; Maggiolo F; Sandkovsky U; Granier C; Pappa K; Wynne B; Min S; Nichols G;
N Engl J Med; 2013 Nov; 369(19):1807-18. PubMed ID: 24195548
[TBL] [Abstract][Full Text] [Related]
33. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
[TBL] [Abstract][Full Text] [Related]
34. Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.
Yang Y; Zhu X; Zhang F; Li W; Wu Y; Ding L
J Pharm Biomed Anal; 2016 Jun; 125():165-77. PubMed ID: 27023129
[TBL] [Abstract][Full Text] [Related]
35. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients.
Yang DH; Xie YJ; Zhao NF; Pan HY; Li MW; Huang HJ
World J Gastroenterol; 2015 Mar; 21(9):2746-53. PubMed ID: 25759545
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel human circulating metabolite of tenofovir disoproxil fumarate with LC-MS/MS.
Nye LC; Gray N; McClure M; Boffit M; Holmes E; Plumb RS; Wilson ID
Bioanalysis; 2015; 7(6):643-52. PubMed ID: 25871584
[TBL] [Abstract][Full Text] [Related]
37. On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors.
Kuklenyik Z; Martin A; Pau CP; Holder A; Youngpairoj AS; Zheng Q; Cong ME; Garcia-Lerma JG; Heneine W; Pirkle JL; Barr JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3659-66. PubMed ID: 19783232
[TBL] [Abstract][Full Text] [Related]
38. Identification of degradation products in loxoprofen sodium adhesive tapes by liquid chromatography-mass spectrometry and dynamic pressurized liquid extraction-solid-phase extraction coupled to liquid chromatography-nuclear magnetic resonance spectroscopy.
Murakami T; Kawasaki T; Takemura A; Fukutsu N; Kishi N; Kusu F
J Chromatogr A; 2008 Oct; 1208(1-2):164-74. PubMed ID: 18778828
[TBL] [Abstract][Full Text] [Related]
39. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
40. Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine.
DeJesus E; Ruane P; McDonald C; Garcia F; Sharma S; Corales R; Ravishankar J; Khanlou H; Shamblaw D; Ecker J; Ebrahimi R; Flaherty J;
HIV Clin Trials; 2008; 9(2):103-14. PubMed ID: 18474495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
